Last €68.08 EUR
Change Today +0.18 / 0.27%
Volume 296.6K
UCB On Other Exchanges
Symbol
Exchange
EN Brussels
OTC US
OTC US
Frankfurt
As of 11:35 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitleKey Developments
Gerhard Mayr 43 RelationshipsChairman of the Board, Member of Audit Committee and Member of Governance, Nomination & Compensation Committee 
Arnoud de Calesberg 51 RelationshipsDirector and Chairman of Audit Committee 
Albrecht De Graeve 49 RelationshipsIndependent Director and Member of Audit Committee 

Compensation Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitle
Diégo du Monceau de Bergendal 29 RelationshipsVice Chairman and Chairman of Governance, Nomination & Compensation Committee
Gerhard Mayr 43 RelationshipsChairman of the Board, Member of Audit Committee and Member of Governance, Nomination & Compensation Committee
Thomas McKillop Ph.D. 129 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation Committee
UCB Compensation vs. Industry
1.4M
427.7K
Chief Executive Officer
Share price activity for UCB SA (UCB)
52 Week Price Performance
UCB
Industry Average

Nominating Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitleKey Developments
Gerhard Mayr 43 RelationshipsChairman of the Board, Member of Audit Committee and Member of Governance, Nomination & Compensation CommitteeBiotie Therapies Corp. and UCB SA Announce Resignation of Peter Fellner as Director
05/8/14
Diégo du Monceau de Bergendal 29 RelationshipsVice Chairman and Chairman of Governance, Nomination & Compensation CommitteeUCB Announces Management Changes
02/21/14
Thomas McKillop Ph.D. 129 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation CommitteeUCB SA Announces Executive Changes
10/17/12

Corporate Governance Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitle
Diégo du Monceau de Bergendal 29 RelationshipsVice Chairman and Chairman of Governance, Nomination & Compensation Committee
Gerhard Mayr 43 RelationshipsChairman of the Board, Member of Audit Committee and Member of Governance, Nomination & Compensation Committee
Thomas McKillop Ph.D. 129 RelationshipsIndependent Director and Member of Governance, Nomination & Compensation Committee
UCB and Competitor
Insiders vs. External
Board
8%
92%
UCB SA
21%
79%
Mylan, Inc.
10%
90%
The Valspar Corporation
0%
100%
K+S Aktiengesellschaft
35%
65%
Grifols, S.A.
9%
91%
Hospira Inc.
Insiders
External Board Members

Executive Committee* - ucb sa (UCB)

Name (Connections)Board RelationshipsTitle
Michele Antonelli 0 RelationshipsFormer Executive Vice President of European Commercial Operations, Member of Executive Committee, Chairman of The Ucb Farchim Board and Managing Director of Ucb France
Frederic Doliveux DVM 42 RelationshipsChief Executive Officer and Executive Director
Greg Duncan 20 RelationshipsFormer Executive Vice President and President of North American Operations
Fabrice Enderlin 0 RelationshipsExecutive Vice President of Corporate of Human Resources, Communication & Corporate Social Responsibility
Ismail Kola Ph.D. 69 RelationshipsExecutive Vice President and President of UCB New Medicines
Iris Löw-Friedrich 9 RelationshipsChief Medical Officer and Executive Vice President of Bio Pharma Development Solutions
Mark McDade 42 RelationshipsExecutive Vice President of Established Brands, Solutions & Supply
Jean-Christophe Tellier 24 RelationshipsExecutive Vice President of Bio Pharma Brands & Solutions and Director
Detlef Thielgen 5 RelationshipsChief Financial Officer and Executive Vice President
Robert Trainor 0 RelationshipsFormer Executive Vice President, General Counsel and Member of Executive Committee
Management Effectiveness Relative to the Industry
Return on Equity
0.2x
Return on Assets
0.3x
Return on Total Capital
0.3x
TEV/Total Revenue(LTM)
0.3x
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UCB:BB €68.08 EUR +0.18

UCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Grifols SA €32.80 EUR +0.335
Hospira Inc $53.44 USD +0.19
K+S AG €24.13 EUR 0.00
Mylan Inc/PA $48.00 USD +0.04
Valspar Corp/The $80.01 USD +0.19
View Industry Companies
 

Industry Analysis

UCB

Industry Average

Valuation UCB Industry Range
Price/Earnings 42.6x
Price/Sales 3.5x
Price/Book 2.6x
Price/Cash Flow 44.0x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UCB SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.